CARLINA Technologies

Carlina Technologies is a biopharmaceutical company specialized in the development of micro- and nano-medicines.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Angers, Pays de la Loire, France
  • Currency EUR
  • Founded July 2010
  • Employees 4
  • Website carlinatech.com

Company Summary

The company provides R&D formulation development services to the pharmaceutical, veterinary and biotechnology industries as well as it develops improved versions of first generation drugs for the treatment of cancer and diabetes using innovative encapsulation platforms.

Team

  • Olivier MEYER
    President & CEO

    Current
    -President & CEO, co-founder at CARLINA Technologies S.A.S.
    Past
    -Consultant, drug delivery systems, drug development, pharmaceuticals.
    -President and Chief Executive Officer at BioxelPharma Inc.
    -Assistant Director at AstraZeneca
    -Vice-President R&D at Bioxalis Medica Inc.
    -Head of Laboratory at Transgene S.A.

    Education
    -University of California, San Francisco
    -Université Paris Sud
    -Université Pierre et Marie Curie

  • Olivier Meyer

Advisors

  • ACR (Avocats Conseils Réunis)
    Lawyer
    Unconfirmed
    Caexis Audit
    Accountant
    Unconfirmed

Previous Investors

  • GO Capital
    Unconfirmed
    Anjou Amorçage
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free